Dr. Caroline Pabst is a senior Physician and Max Eder Research Group Leader at the clinic for Hematology, Oncology and Rheumatology of University Hospital Heidelberg. Her research focuses on identifying specific gene networks in AML with high molecular genetic risk using NGS technology, proteomics and in vivo models. With this her lab aims to better understand the biology of normal and malignant stem cells and to develop more efficient therapies for AML patients.
